Table 2: Characteristics of THN administration events from BCTHN program records (n = 64*)
Event characteristicn (%)Event characteristicn (%)
Naloxone administered toSymptoms of withdrawal
A third party (by the person who was prescribed the kit)41(64.1)None29(45.3)
Self 15(23.4)Mild18(28.1)
To a person who was prescribed the kit (by a third party)2 (3.1)Severe8(12.5)
Unknown6 (9.4)Unknown1 (1.6)
Location of overdoseNo reply8(12.5)
Private residence43(67.2)Display of aggression
On the street9(14.1)Yes9(14.1)
Hotel5 (7.8)No41(64.1)
Supportive housing3 (4.7)No reply14(21.9)
Other2 (3.1)No. of ampoules administered
Shelter0 (0.0)131(48.4)
No reply2 (3.1)1.51 (1.6)
Drugs involved (individuals could give more than 1 answer)223(35.9)
Heroin60(93.8)3 1 (1.6)
Fentanyl12(18.8)No reply8(12.5)
Methamphetamine8(12.5)911 called
Cocaine/crack8(12.5)Yes25(39.1)
Methadone7(10.9)No38(59.4)
Morphine4 (6.3)No reply1 (1.6)
Benzodiazepines4 (6.3)If 911 not called (n = 38), why?
Codeine2 (3.1)Police involvement17(44.7)
Oxycodone2 (3.1)Would recover on own15(39.5)
Alcohol2 (3.1)No reply6(15.8)
GHB1 (1.6)If 911 called (n = 25), did police attend?
Other6 (9.4)Yes13(52.0)
No reply1 (1.6)No12(48.0)
No reply0 (0.0)

Note: N = number of overdose reversals, GHB = γ-hydroxybutyric acid.
*Two events were excluded from the analysis because paramedics arrived before naloxone was administered.